Health in Code’s inherited heart disease studies awarded the UNE-EN ISO 15189 accreditation
Health in Code, a company specialized in clinical genetics services, has obtained the renowned accreditation from the Spanish National Accreditation Body (ENAC), which attests to its competence in performing genetic analysis of inherited heart diseases according to the requirements of the internationally recognized UNE-EN ISO 15189 standard. This accreditation endorses Health in Code’s performance excellence in the study of 218 genes related to inherited cardiomyopathies and channelopathies.
This achievement constitutes an unprecedented milestone, making Health in Code a groundbreaking laboratory by simultaneously obtaining the UNE-EN ISO 15189 accreditation for both massive parallel sequencing (NGS) and Sanger sequencing techniques, which are considered fundamental and complementary approaches to ensure optimal results of genetic analyses.
With the goal of generating reliable and accurate genetic information to support clinical diagnosis, Health in Code maintains a strong commitment to quality in its daily work and in all its processes. This accreditation mainly reflects a quality management policy in place since the creation of the company, which has been corroborated by different national and international bodies.
The trust and reliability inherent to the UNE-EN ISO 15189 accreditation provide Health in Code with a highly distinctive advantage, which will positively influence its competitiveness in international markets, where it already stands among the leading companies in the field.